Development and validation of a nomogram for predicting the risk of vasovagal reactions after plasma donation

被引:1
|
作者
Zhao, Peizhe [1 ,2 ,3 ]
Dong, Demei [4 ]
Dong, Rong [5 ]
Zhou, Yuan [1 ]
Hong, Yan [6 ]
Xiao, Guanglin [2 ]
Li, Zhiye [1 ]
Su, Xuelin [5 ]
Zheng, Xingyou [5 ]
Liu, Xia [5 ]
Zhang, Demei [1 ,8 ]
Li, Ling [7 ]
Liu, Zhong [2 ,3 ]
机构
[1] Taiyuan Blood Ctr, Dept Blood Transfus, Taiyuan, Shanxi, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Inst Blood Transfus, Chengdu, Sichuan, Peoples R China
[3] CAMS, Key Lab Transfus Adverse React, Chengdu, Sichuan, Peoples R China
[4] Beijing Tiantan Biol Prod Co Ltd, Dept Qual Control, Beijing, Peoples R China
[5] Jianyang Rongsheng Apheresis Plasma Co Ltd, Dept Plasma Apheresis, Jianyang, Sichuan, Peoples R China
[6] Shifang Rongsheng Apheresis Plasma Co Ltd, Dept Plasma Apheresis, Shifang, Sichuan, Peoples R China
[7] Southwest Jiaotong Univ, Peoples Hosp Chengdu 3, Dept Blood Transfus, Affiliated Hosp, Chengdu, Sichuan, Peoples R China
[8] Taiyuan Blood Ctr, Dept Blood Transfus, 185 Yingze West St, Taiyuan, Shanxi, Peoples R China
关键词
donor health; nomogram; plasma donation; prediction model; vasovagal reaction; BLOOD-DONATION; MULTICENTER; DONORS; CANCER; SAFETY; FEAR;
D O I
10.1002/jca.22074
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and Objectives: Vasovagal reactions (VVRs) are the most common adverse reactions and are frequently associated with serious donor adverse events. Even mild VVRs can lead to a significant reduction in the likelihood of subsequent donations. The purpose of this study is to explore the factors related to the occurrence of VVRs after plasma donation and to construct a nomogram to identify individuals at risk for VVRs to improve the safety of plasma donors.Materials and Methods: We collected the donation data from July 2019 to June 2020 from a plasma center in Sichuan, China, to explore the independent risk factors for vasovagal reactions. From these data, we constructed and validated a predictive model for vasovagal reactions.Results: VVRs after plasma donation occurred 737 times in 120 448 plasma donations (0.66%). Gender, season, donor status, weight, pulse, duration of donation, and cycle were independent risk factors for VVRs (P< 0.05). The concordance index (C-index) of a logistic model in the derivation cohort was 0.916, with a Hosmer-Lemeshow goodness-of-fit probability of 0.795. The C-index of a logistic model in the validation cohort was 0.916, with a Hosmer-Lemeshow goodness-of-fit probability of 0.224. The calibration curve showed that the predicted results were in good agreement with the actual observed results.Conclusion: This study preliminarily constructed and verified a prediction model for VVRs after plasma donation. The model nomogram is practical and can identify high-risk donors.
引用
收藏
页码:622 / 631
页数:10
相关论文
共 50 条
  • [21] Development and validation of a nomogram for predicting the risk of poor prognosis in patients with cerebral infarction
    Chen, Zhenfeng
    Zhang, Lixiang
    Li, Rui
    Hu, Haiying
    Hu, Qiongdan
    Chen, Xia
    HELIYON, 2024, 10 (01)
  • [22] Development and Internal Validation of a Nomogram for Predicting Renal Function after Partial Nephrectomy
    Bertolo, Riccardo
    Garisto, Juan
    Li, Jianbo
    Dagenais, Julien
    Kaouk, Jihad
    EUROPEAN UROLOGY ONCOLOGY, 2019, 2 (01): : 106 - 109
  • [23] Development and Validation of a Risk Nomogram Model for Predicting Recurrence in Patients with Atrial Fibrillation After Radiofrequency Catheter Ablation
    Zhao, Zhihao
    Zhang, Fengyun
    Ma, Ruicong
    Bo, Lin
    Zhang, Zeqing
    Zhang, Chaoqun
    Wang, Zhirong
    Li, Chengzong
    Yang, Yu
    CLINICAL INTERVENTIONS IN AGING, 2022, 17 : 1405 - 1421
  • [24] Development and Validation of a Nomogram for Predicting Postoperative Pulmonary Infection in Patients Undergoing Lung Surgery
    Wang, Jing-Yun
    Pang, Qian-Yun
    Yang, Ya-Jun
    Feng, Yu-Mei
    Xiang, Ying-Ying
    An, Ran
    Liu, Hong-Liang
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2022, 36 (12) : 4393 - 4402
  • [25] Development and Validation of a Nomogram Predicting the Prognosis of Renal Cell Carcinoma After Nephrectomy
    Xia, Mancheng
    Yang, Haosen
    Wang, Yusheng
    Yin, Keqiang
    Bian, Xiaodong
    Chen, Jiawei
    Shuang, Weibing
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 4461 - 4473
  • [26] Development and validation of a lung metastases-predicting nomogram for intermediate- to high-risk differentiated thyroid carcinoma patients
    Ma, Wenhui
    Yu, Feng
    Chen, Bowen
    Yang, Zhiping
    Kang, Fei
    Li, Xiang
    Yang, Weidong
    Wang, Jing
    FUTURE ONCOLOGY, 2024, 20 (22) : 1575 - 1586
  • [27] Development and external validation of a nomogram predicting prognosis of upper tract urothelial carcinoma after radical nephroureterectomy
    Zeng, Shuxiong
    Dai, Lihe
    Yang, Jun
    Gao, Xiaomin
    Yu, Xiaowen
    Ren, Qian
    Wang, Kaijian
    Xu, Jinshan
    Yang, Zeyu
    Yang, Bo
    Wang, Huiqing
    Yang, Qing
    Ye, Huamao
    Hou, Jianguo
    Pan, Yue
    Zhang, Zhensheng
    Weng, Zhiliang
    Sun, Yinghao
    Xu, Chuanliang
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2019, 37 (04) : 290.e17 - 290.e24
  • [28] Development and validation of a nomogram for predicting CRBSI in hemodialysis: a retrospective cohort study
    Shan Wu
    Fan Dai
    Yanhong Wen
    Chang Luo
    Chuanfang Wu
    BMC Nephrology, 26 (1)
  • [29] Development and Validation of a Nomogram for Predicting Generalization in Patients With Ocular Myasthenia Gravis
    Ruan, Zhe
    Sun, Chao
    Lang, Yanlin
    Gao, Feng
    Guo, Rongjing
    Xu, Quan
    Yu, Liping
    Wu, Songdi
    Lei, Tao
    Liu, Yu
    Zhang, Min
    Li, Huanhuan
    Tang, Yonglan
    Gao, Ting
    Gao, Yanwu
    Lu, Xiaodan
    Li, Zhuyi
    Chang, Ting
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [30] Development and Validation of a Nomogram for Predicting Risk of Emergency Department Revisits in Chinese Older Patients
    Fan, Lijun
    Xue, Hui
    Wang, Qian
    Yan, Yuhan
    Du, Wei
    RISK MANAGEMENT AND HEALTHCARE POLICY, 2022, 15 : 2283 - 2295